Drug
Vinblastine clinical trials
Also written Velban and 29060-LE.
- studies test it
- 87
- open now
- 9
- in phase 3
- 24
- first study started
- 1992
Keep track of what changes. Save the Vinblastine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
87 studies that test it; most in 1997 (7)
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1994 | 1 |
| 1995 | 1 |
| 1996 | 2 |
| 1997 | 7 |
| 1998 | 2 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 12
- Phase 2
- 52
- Phase 3
- 24
- Phase 4
- 3
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 83
M.D. Anderson Cancer Center (7) · St. Jude Children's Research Hospital (5) · Children's Oncology Group (5) · National Cancer Institute (NCI) (4) · SWOG Cancer Research Network (4) · Alliance for Clinical Trials in Oncology (4) · University of Cologne (4) · European Organisation for Research and Treatment of Cancer - EORTC (3)
Often tested with
Tested in the same studies.
Doxorubicin (43) · Dacarbazine (26) · Methotrexate (21) · Cisplatin (18) · Cyclophosphamide (16) · Bleomycin (15) · Prednisone (14) · Etoposide (13)
Studies
Open first, then newest update. How each study uses Vinblastine is read from its arms, and is right about nine times in ten.
Testing it · 87
- Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerRecruitingPhase 2/3National Cancer Institute (NCI)NCT04628767Written as Vinblastine Sulfate
- Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin LymphomaRecruitingPhase 2University of WashingtonNCT06745076Written as Vinblastine
- Drug Screening Using IMD in Bladder CancerEnrolling by invitationEarly Phase 1Brigham and Women's HospitalNCT06204614Written as Vinblastine
- A Study of BV-AVD in People With Bulky Hodgkin LymphomaRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT06377566Written as Vinblastine
- A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in IndiaRecruitingPhase 4TakedaNCT06831370Written as Vinblastine
- Nivo40-AVD for Advanced Classic Hodgkin LymphomaRecruitingPhase 2National Medical Research Radiological Centre of the Ministry of Health of RussiaNCT06984146Written as Vinblastine
- Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade GliomasRecruitingEarly Phase 1Daniel MorgensternNCT06381570Written as Vinblastine
- First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)RecruitingPhase 3State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of RussiaNCT04638790Written as Vinblastine
- Vinblastine for Leukoreduction in Newly Diagnosed AML and HyperleukocytosisRecruitingPhase 2Hospital Universitario Dr. Jose E. GonzalezNCT05062278Written as Vinblastine
- Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsTerminatedPhase 1/2Centre Oscar LambretNCT03585465Written as Vinblastine
- Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin LymphomaActive, not recruitingPhase 2Academic and Community Cancer Research UnitedNCT03233347Written as Vinblastine
- Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II StudyActive, not recruitingPhase 2European Organisation for Research and Treatment of Cancer - EORTCNCT03517137Written as Vinblastine
- A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade GliomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT04576117Written as Vinblastine Sulfate
- Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17Active, not recruitingPhase 2St. Jude Children's Research HospitalNCT03755804Written as Vinblastine
- Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin LymphomaCompletedPhase 2Northwestern UniversityNCT01476410Written as vinblastine
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell HistiocytosisActive, not recruitingPhase 2/3North American Consortium for HistiocytosisNCT02205762Written as Vinblastine
- A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin LymphomaActive, not recruitingPhase 1/2TakedaNCT02979522Written as Vinblastine
- FIL Study on ABVD DD-DI as Upfront Therapy in HL.CompletedPhase 3Fondazione Italiana Linfomi - ETSNCT03159897Written as Vinblastine
- Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin LymphomaCompletedPhase 1/2University of WashingtonNCT03331341Written as Vinblastine
- S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder CancerCompletedPhase 2SWOG Cancer Research NetworkNCT02177695Written as Vinblastine
See all 87 studies that test Vinblastine →
Given in every arm · 38 — Vinblastine is usual care beside what is tested
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruitingPhase 3National Cancer Institute (NCI)NCT05675410Written as Vinblastine Sulfate
- Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)RecruitingPhase 2AstraZenecaNCT06960577Written as Vinblastine
- Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHLRecruitingPhase 2M.D. Anderson Cancer CenterNCT07551583Written as Vinblastine
- Brentuximab Vedotin in Early Stage Hodgkin LymphomaRecruitingPhase 3University College, LondonNCT04685616Written as Vinblastine
- Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCLRecruitingPhase 2New York Medical CollegeNCT07013565Written as Vinblastine (Velban)
- Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin LymphomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT03907488Written as Vinblastine Sulfate
- Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)Active, not recruitingPhase 2Merck Sharp & Dohme LLCNCT03407144Written as vinblastine
- A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the BladderActive, not recruitingPhase 2M.D. Anderson Cancer CenterNCT05137262Written as Vinblastine
- Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin LymphomaActive, not recruitingPhase 2Northwestern UniversityNCT06164275Written as Vinblastine
- Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaCompletedNot applicableMemorial Sloan Kettering Cancer CenterNCT01868451Written as Vinblastine Sulfate
- Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)CompletedPhase 2Fox Chase Cancer CenterNCT02710734Written as Vinblastine
- Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and AboveActive, not recruitingPhase 2University of VirginiaNCT05404945Written as Vinblastine
- A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin LymphomaCompletedPhase 3TakedaNCT01712490Written as vinblastine
- A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)Active, not recruitingPhase 1/2Memorial Sloan Kettering Cancer CenterNCT03033914Written as vinblastine
- Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder CancerCompletedPhase 2University of WashingtonNCT04383743Written as Vinblastine Sulfate
- Clinical Trial of Brentuximab Vedotin in Classical Hodgkin LymphomaTerminatedPhase 2Seagen Inc.NCT03646123Written as vinblastine
- Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin LymphomaCompletedPhase 1/2National Cancer Institute (NCI)NCT01771107Written as Vinblastine
- Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)CompletedPhase 2Merck Sharp & Dohme LLCNCT05008224Written as Vinblastine
- Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin LymphomaCompletedPhase 2University of CologneNCT03004833Written as Vinblastine
- Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin LymphomaActive, not recruitingPhase 2City of Hope Medical CenterNCT03712202Written as Vinblastine
Showing 20 of 38.
As the comparator · 9 — what is tested is compared with Vinblastine
- Pediatric Low Grade Glioma - MEKinhibitor TRIal vs ChemotherapyRecruitingPhase 2University Hospital, Strasbourg, FranceNCT05180825Written as Vinblastine
- PAZOPANIB Efficacy and Tolerance in Desmoids TumorsCompletedPhase 2Institut BergoniéNCT01876082Written as Active Comparator: Vinblastine and Methotrexate
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's LymphomaCompletedPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT00049595Written as vinblastine sulfate
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin LymphomaCompletedPhase 3University College, LondonNCT00678327Written as vinblastine sulfate
- Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and LymphomaCompletedPhase 2St. Jude Children's Research HospitalNCT01700946Written as vinblastine
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin LymphomaCompletedPhase 2SWOG Cancer Research NetworkNCT00822120Written as vinblastine sulfate
- Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial ProtocolStatus unknownNot applicableLee's Pharmaceutical LimitedNCT02800447Written as ABVD
- Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)Status unknownPhase 2Ospedale Santa Croce-Carle CuneoNCT00795613Written as CONVENTIONAL ABVD
- Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's LymphomaCompletedPhase 3Fondazione MichelangeloNCT01251107Written as Vinblastine
Codes
What other systems call Vinblastine · ClinicalTrials.gg INT008407
- MeSH (NLM) D014747VinblastineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5V9KLZ54CYVINBLASTINEConfirmed FDA, NLM, Wikidata
- RxNorm 11198Confirmed FDA, Wikidata
- Wikidata Q282629vinblastineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C930VinblastineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014747 | Vinblastine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5V9KLZ54CY | VINBLASTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 11198 | — | Confirmed FDA, Wikidata |
| Wikidata | Q282629 | vinblastine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C930 | Vinblastine | One source FDA |
Also registered as vinblastine sulfate (UNII N00W22YO2B · RxNorm 11199).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.